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Abstract
We used human fetal bone marrow-derived mesenchymal stromal cells (hfMSCs) differentiating towards chondrocytes as an
alternative model for the human growth plate (GP). Our aims were to study gene expression patterns associated with
chondrogenic differentiation to assess whether chondrocytes derived from hfMSCs are a suitable model for studying the
development and maturation of the GP. hfMSCs efficiently formed hyaline cartilage in a pellet culture in the presence of
TGFb3 and BMP6. Microarray and principal component analysis were applied to study gene expression profiles during
chondrogenic differentiation. A set of 232 genes was found to correlate with in vitro cartilage formation. Several identified
genes are known to be involved in cartilage formation and validate the robustness of the differentiating hfMSC model.
KEGG pathway analysis using the 232 genes revealed 9 significant signaling pathways correlated with cartilage formation.
To determine the progression of growth plate cartilage formation, we compared the gene expression profile of
differentiating hfMSCs with previously established expression profiles of epiphyseal GP cartilage. As differentiation towards
chondrocytes proceeds, hfMSCs gradually obtain a gene expression profile resembling epiphyseal GP cartilage. We
visualized the differences in gene expression profiles as protein interaction clusters and identified many protein clusters that
are activated during the early chondrogenic differentiation of hfMSCs showing the potential of this system to study GP
development.
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Introduction
Longitudinal bone growth is the result of a tightly orchestrated
proliferation and differentiation program called endochondral
ossification. In the epiphyseal growth plate, chondrocytes origi-
nating from mesenchymal stromal cells subsequently undergo
proliferation, hypertrophic differentiation, and programmed cell
death before being replaced by bone. At the time of puberty,
growth first increases but at the end of puberty epiphyseal fusion
and termination of growth occurs. Although estrogen has been
identified as a key regulator of growth plate maturation and fusion
[1], our knowledge of the molecular mechanisms underlying
human growth regulation during puberty is limited. Gaining a
detailed understanding of growth regulatory processes is essential
to facilitate the development of novel strategies for the treatment of
various growth disorders.
Commonly used animal models for studying growth plate
regulation represent the human epiphyseal growth plate poorly.
One of the most obvious differences is that rodent growth plates do
not fuse at the end of sexual maturation [2], an important
hallmark of human growth plate development. The shortcoming
of the mouse model is furthermore demonstrated by the contrast
between the marginally affected growth phenotype of the estrogen
receptor alpha (ERa) knock out mouse (aERKO) [3] and the
prominent growth phenotype of a male patient lacking functional
ERa [4], which is characterized by the absence of epiphyseal
fusion and continuation of growth into adulthood.
In order to elucidate the mechanisms involved in growth plate
regulation and fusion, we need to employ different strategies. The
most optimal strategy would be to investigate these processes in
human growth plate specimens at different times during develop-
PLOS ONE | www.plosone.org 1 November 2012 | Volume 7 | Issue 11 | e44561
ment. However, human growth plate specimens are difficult to
obtain [5]. In vitro models such as chondrosarcoma cell lines or
articular cartilage-derived chondrocyte cultures have limited
differentiation capacity, are often difficult to maintain under
laboratory conditions or tend to dedifferentiate [6,7]. Further-
more, articular cartilage and growth plate cartilage have distinct
functions and it is therefore debatable whether articular cartilage-
derived chondrocytes are representative for epiphyseal growth
plate chondrocytes.
Multipotent human mesenchymal stromal cells (hMSCs) are
promising for studying chondrogenesis in vitro. hMSCs are an
alternative cell source for articular cartilage reconstruction and for
studying endochondral ossification as it occurs in the epiphyseal
growth plate [8]. In addition, we found that MSCs in co-culture
with chondrocytes contribute greatly to better cartilage generation
in vitro [9]. In this study, we explored the cartilage forming
capacity of human fetal (hf)MSCs in time. In addition, we
explored whether differentiating hfMSCs may provide an in vitro
model for the human growth plate. We have chosen human fetal
bone marrow-derived MSC for their superior differentiation
characteristics compared to adult bone marrow-derived MSCs
[10]. Efficient cartilage formation was demonstrated by immuno-
histochemical analysis and gene expression profiling was applied to
identify genetic pathways involved in the differentiation process. In
addition, gene expression profiles of the differentiating hfMSCs
were compared with global gene expression patterns of human
articular and growth plate cartilage to assess whether differenti-
ating hfMSCs represent either articular or growth plate chondro-
cytes.
Results
2.1 Chondrogenically differentiating hfMSCs express
typical markers of hyaline cartilage
2.1.1. Evaluation of protein and mRNA expression. Two
major types of hyaline cartilage can be distinguished, namely
articular and epiphyseal cartilage. In order to serve as a model for
the epiphyseal growth plate, differentiating hfMSCs should obtain
a growth plate signature.
Pellet cultures were used to induce chondrogenic differentiation
of hfMSCs and samples were collected at 1, 2, 3, 4 and 5 weeks of
culture. Immunohistological evaluation showed an increasing
expression of cartilage markers with time and a gradual
morphological change from stromal cells to mature and hyper-
trophic chondrocytes (Figure 1). The mean diameter of the pellets
increased with time, as well as the amount of glycosaminoglycans,
a major constituent of the cartilaginous extracellular matrix.
Immunofluorescent staining for collagen type II demonstrated the
presence of chondrocytes after 1 week of pellet culture. The
expression of collagen type II increased over time. Hypertrophic
chondrocytes were first detected after 3 weeks, as evidenced by
immunohistochemical staining for collagen type X. These collagen
type X positive cells were located in a discrete ring-like zone
surrounded by collagen type II positive chondrocytes. In all stages
of differentiation, the chondrogenic core of the pellets was
surrounded by a thin layer of two to three undifferentiated cells
(Figure 1). Matrix mineralization was not observed after 5 weeks of
differentiation (data not shown), suggesting that the matrix was not
ready for mineralization or that environmental stimuli necessary to
induce this process were absent.
From each time point RNA was isolated and subjected to
microarray analysis. Changes in gene expression of a subset of
genes consisting of both established marker genes for chondro-
genesis and differentially expressed genes identified by microarray
analysis were validated using qPCR (Figure S1). In concordance
with the observations of immunohistological markers of chondro-
genesis, microarray data and qPCR showed time-dependent
increases in the expression of the cartilage markers COL2A1,
‘COL10A1, SOX9, and ACAN mRNA.
Previously, we have shown that chondrogenic differentiation of
MSCs results in a growth plate (GP-) like rather than an articular
phenotype [11]. In this study, we compared the gene expression
profiles of human articular cartilage to human growth plate
cartilage of the same donors. Global gene expression microarray
analysis showed that the Wnt antagonist DKK1 and FRZB and
the BMP antagonist GREM1 are highly expressed in articular
cartilage as compared to growth plate cartilage. In contrast,
PANX3, EPYC, WNT11 and LEF1 are highly expressed in
growth plate cartilage as compared to articular cartilage. To
investigate whether the differentiation of the hfMSCs in the
chondrogenic lineage results in expression of markers specifically
found in the GP vs AC, we selected genes that are significantly
differentially expressed in these two types of hyaline cartilage; for
GP: PANX3, EPYC, WNT11, LEF1, and for AC: GREM1, FRZB,
DKK1.
We observed a sharp increase in the expression of PANX3,
EPYC and LEF1 (GP enriched genes) in the differentiating MSCs
while the AC enriched genes FRZB, and DKK1 showed a marked
decrease in their expression over time (figure 2). The gene
expression of GREM1 hardly changed over time. This indicates
that the cells acquire a GP-like expression profile early during the
differentiation.
2.1.2. Principal component analysis and KEGG pathway
analysis identifies 9 pathways associated with chondrogenic
differentiation. The sequential changes that occur during
chondrogenic differentiation in the hfMSC model were studied
with bioinformatics analysis of the microarray data. Using
principal component analysis, three components were found to
explain 99.6% of the variance within our dataset (figure 3A). The
factor loadings in figure 3B show that component 1 describes a
general level of gene expression, as expected. Component 2 shows
to what extent gene expression changed with time during
chondrogenic differentiation and component 3 signifies there
was an additional, short-term elevation or dip in expression
around 2 to 3 weeks of differentiation. Since components 2 and 3
were most likely to contain genes associated with the loss of
stromal cell characteristics or the gain of a chondrocyte phenotype,
we focused on those components.
Using the $3.29 cut-off in combination with a 5% significance
test, we distinguished four subgroups of probes. The precise
definitions and the resulting numbers of these subgroups are given
in figure 3C. The scatter plot in figure 3D illustrates that the
numbers of probes in subgroups 1 and 2 are much larger than the
9 probes (0.05%) that would have been expected under purely
random selection. Moreover, in these two subgroups nearly all
probes in the first selection are significant at the 5% level,
suggesting that the number of false discoveries in these two groups
is quite small. More noise is presumably present in the smaller
subgroups 3 and 4 based on factor 3 scores.
The profiles of the selected probes demonstrate that subgroup 1
containing the largest number of probes (n = 146) describes a peak
of expression on t0 (week 0) followed by a decrease in expression
thereafter. In contrast, the second largest subgroup of probes
(n = 105) in profile 2 demonstrates increasing expression levels
from t0 onward. The smaller subgroups 3 and 4 demonstrate lower
levels of expression with profile 3 (n = 49) showing a short-term
increase in expression at t1 (week 1) followed by decreases
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thereafter and profile 4 (n = 15) displaying a short-term expression
dip between t1-t2 (week 1- week 2).
A total of 83 out of 315 probes could not be annotated and was
discarded from further analysis. The remaining 232 probes that
could be matched to genes (table S1) were used to identify 9
KEGG pathways that were significantly associated with chondro-
genic differentiation and contained 39 genes (figure 4). Some genes
were present solely in one pathway (n = 23), but others were found
in 2 (n= 6) or 3 (n = 10) pathways (Figure 4). Three functional
groups of genes were recognized: 1) growth factor (GF) and GF-
related genes; 2) genes associated with the extracellular matrix;
and 3) genes associated with signal transduction, cell cycle, and cell
survival. In table S2, we have listed the top hits of upregulated and
down-regulated genes (with a cut-off of at least 3.29-fold change)
as identified by the microarray analysis at week 5 compared to
undifferentiated hfMSCs.
2.1.3 Network analysis of significantly changed genes
identifies many chondrogenesis associated clusters. In
order to identify protein-protein interactions between proteins
encoded by genes shown in table S2 STRING 9.0 (http://string-
db.org) was used (figure 5). The clusters identified include many
proteins involved in skeletal development and regulation of ECM
homeostasis (figure 5 A, E), such as ACAN, COL2A1,
ADAMTS5, PTH1R and GDF5, transcription regulators
(figure 5C), such as JUN and FOS, as well as a node containing
TGFb superfamily proteins (figure 5B), such as GREM1. In
addition, WNT11 and FZD2 seem to play a role in the
chondrogenic differentiation of hfMSCs. We propose that if
proteins in a related network mode change simultaneously, this
increases the likelihood that these proteins play an important role
in the differentiation of the hfMSCs toward the chondrogenic
lineage.
2.2 hfMSCs acquire a partial GP phenotype after 5 weeks
of differentiation
Histological and gene expression analyses showed that the
differentiating hfMSCs acquired a hyaline cartilage phenotype. In
order to investigate how the expression profile changes from a
MSC toward a GP profile we compared the gene profiles of the
primary hfMSCs with prepubertal GP samples and identified
many genes that are differentially expressed (table S3). In order to
visualize the protein-protein interactions of the proteins encoded
by these genes, we used STRING9.0. STRING (Search Tool for
the retrieval of Interaction Genes/Proteins) is a freely available
tool to visualize known and predicted protein interactions [12]. As
such, it visualizes underlying protein networks that that are
significantly changed within our data set. Interestingly, there is a
large overlap of clusters identified in the profiles of MSC week 0
vs. MSC week 5 (figure 5) and the profile of MSC week 0 vs
prepubertal GP (figure 6). Note that these clusters are based on
protein-protein interactions, and not functional similarities.
Protein clusters include ECM related proteins (figure 6A, E),
TGFb superfamily related proteins and their interactants
(figure 6B), transcription regulatory proteins (figure 6C), and
cytoskeleton related proteins (figure 6D. In addition, a large cluster
containing proteins that are important in chondrocyte hypertro-
phy is visible in the MSC vs. GP data.
Figure 1. hfMSCs micromasses undergo chondrogenic differentiation. Expression of (A) glycosaminoglycans visualized by toluidine blue
staining, nuclei are counterstained with haematoxylin, (B) collagen type II immunofluorescence, and (C) collagen type X immunohistochemistry (red-
brown) during 5 weeks of chondrogenic differentiation of hfMSCs to chondrocytes. The top panel shows a magnification of the pellet cultures at
week 1 and week 5 stained by toluidine blue demonstrating the change in cell morphology and the deposition of the extracellular matrix. The insets
in panel B show higher magnifications of collagen type II positive chondrocytes.
doi:10.1371/journal.pone.0044561.g001
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Figure 5A depicts a large cluster of ECM related proteins that
change over 3.29 fold between week 0 vs. week 5. The expression
of genes encoding cartilaginous ECM proteins, such as collagens
(COL1A1, COL1A2, COL2A1, COL5A2, COL11A1), chondroad-
herin (CHAD), cartilage oligomeric matrix protein (COMP),
secreted phosphoprotein 1 (osteopontin, SPP1), and fibronectin
type III (FNDC1), was up regulated. Growth and differentiation
factor 5 (GDF5), previously reported as stimulator of chondrocyte
proliferation [13], was highly expressed at the earliest time point
observed and down regulated thereafter.
Cluster 5B depicts proteins involved in TGFb signaling. BMP2
and its downstream effector ID3 are up regulated early in
differentiation consistent with previous reports on the importance
of BMP signaling in chondrogenesis [14,15]. The BMP inhibitor
follistatin (FST) was highly expressed at the earliest time point, and
down regulated at later times and was previously shown to be
expressed by proliferative, but not by hypertrophic chondrocytes
[16]. This is in concordance with the observation of Kearns et al,
who described the activation of a feedback loop in which the
expression of follistatin is induced by BMP2 [17].
Cluster 5C depicts proteins interactions with a variety of
functions, such as regulation of transcription, coagulation, matrix
mineralization and early hypertrophic differentiation. Members of
the complement and coagulation family of proteins were expressed
during in vitro chondrogenic differentiation. Coagulation factor
XIII (F13A1) expression was up regulated, while other genes like
complement component I (C1R), urokinase-type plasminogen
activator (PLAU) and bradykinin receptor B2 (BDKRB2) were
downregulated during differentiation in our model. These proteins
are associated with matrix mineralization [18–20] or matrix
degradation in the growth plate [21–23], indicating early
hypertrophic differentiation in the model, but not late hypertro-
phy. Proto-oncogene KIT (cluster F, hypertrophy related genes),
transcription factor JUN and FOS are all associated with the
regulation of cell proliferation [24,25]. Cluster 5C depicts several
genes involved in the regulation of cell survival and proliferation
and signal transduction. Caveolin 1 (CAV1), a multifunctional
scaffolding protein located at cell surface caveolae, regulates TGF,
Wnt, cytokine and VEGF signaling by modulating their down-
stream signaling cascades such as the JAK/STAT, b-catenin/
LEF1, MAPK/ERK and PI3K/AKT signaling pathways [26–29].
In cluster D we find proteins involved in cell cycle regulation.
Expression of the nuclear envelope protein lamin B2 (LMNB2,
interacts with proteins in cluster D) was first up regulated and later
in differentiation down regulated in our model. Constantinescu et
al describe that B-type lamins are differentially expressed during
different stages of ESC differentiation and suggest a role of these
nuclear envelope proteins in the regulation of of the differentia-
tion. [30]. The role for LMNB2 in chondrogenic differentiation is
not known, but the changes in gene expression during chondro-
genic differentiation may imply a role for regulation of the timing
of hypertrophic differentiation in our in vitro cultures.
In figure 6 we identify the same clusters of interacting protein as
in figure 5. The comparison between these images gives us insight
into the route that MSCs take toward the differentiation into
growth plate cartilage. The most obvious difference between the
clusters identified in figure 5 and the ones in figure 6 is cluster 6E,
which contains many proteins involved in late hypertrophic
differentiation. Other genes showing significant differences in
expression are clustered in the same groups, but the changes in
gene expression profile between growth plate chondrocytes and
undifferentiated MSCs is larger than that between week 0 and
Figure 2. Increase in growth plate enriched genes and decrease of articular cartilage enriched genes in time. Expression of growth
plate enriched genes PANX3, EPYC, LEF1 and articular cartilage enriched genes DKK1, FRZB, GREM1 during 4 weeks of chondrogenic differentiation of
hfMSCs. The y-axis (left) indicates the qPCR results as normalized fold expression on a log-scale. The x-axis (right) indicates the time in weeks. Fold
changes are calculated from qPCR data expressed as delta delta CT values corrected for the housekeeping gene GAPDH.
doi:10.1371/journal.pone.0044561.g002
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week 5 differentiated MSCs. The presence of the most important
nodes in larger protein interaction clusters, emphasize that this
cannot be a casualty. In the differentiating MSCs we identified a
steep increase in expression of the early hypertrophic marker
COL10A1, however, the addition of many more hypertrophic
markers in the GP samples indicate that in order to fully form GP
cartilage, MSCs will have to activate genes that induce later stages
of hypertrophy.
Discussion
3.1 hfMSCs can serve as a model for human growth plate
development
In this study we identified many protein clusters involved in the
differentiation of hfMSCs toward chondrocytes. In order for
hfMSCs to serve as a model for the development of the epiphyseal
growth plate, the cells need to obtain gene expression profiles that
contain protein clusters that have been shown to play functional
roles in the different stages of growth plate development. Fetal
human bone marrow-derived MSCs seem to display better
chondrogenic differentiation capacity than adult MSCs [10].
Consequently, it seems appropriate to use fetal bone marrow-
derived MSCs as a model for chondrogenesis. However, fetal
MSCs are not easily obtained, due to ethical and legal
considerations, and as a consequence, adult bone marrow-derived
MSCs have been used in most previous studies [31–34].
Previously, we have demonstrated that the hfMSCs differenti-
ating towards chondrocytes acquired a GP cartilage-like pheno-
type [11]. Chondrogenic differentiation occurred in our in vitro
model, as illustrated by the progressive increase in expression of
the chondrocyte markers collagen type II and X and the
cartilaginous matrix constituent glycosaminoglycan over time.
Interestingly, hypertrophic differentiation as evidenced by an
increase in cell size and positive staining for collagen X was only
observed in a discrete zone of the pellet, which was surrounded at
both sites by chondrocytes positive for collagen type II. Further
confirmation of chondrogenesis was obtained by analysis of
mRNA expression of cartilage markers, which, in addition, also
validated our microarray results. Similar gene expression patterns
were obtained during chondrogenic differentiation of fetal MSCs
derived from other donors. This suggested that the selected 22
weeks old fetal MSC-donor was representative for fetal bone
marrow in general.
Most studies in which MSCs are used to produce cartilage are
aimed at obtaining articular cartilage. Cartilage matrix analysis is
often limited to examining collagen type 2 and aggrecan
expression. These markers are characteristic for hyaline cartilage
and cannot distinguish growth plate cartilage from articular
cartilage. Indeed, Huang et al. performed global microarray
analysis of adult bovine MSCs at time 0 and after 28 days of
differentiation in agarose constructs and compared the gene
expression profile to that of chondrocytes isolated from articular
cartilage. They showed that chondrogenically differentiating MSC
do not form articular cartilage at 28 days in the presence of
TGFb3 [35]. This is in line with our present and previous study
[11].
Although many pathways are involved in chondrocyte differ-
entiation, all the studies leading to the identification of these
pathways have been performed in animal chondrocytes and the
number of studies using human chondrocytes is limited. A recent
publication of our group identified 3 soluble antagonists to the
Wnt and BMP pathway as highly expressed in articular cartilage
and not growth plate cartilage [36]. In this article, we showed that
when MSCs differentiate towards chondrocytes, they adopt a GP-
like phenotype, whereas the addition of recombinant DKK1,
GREM1 and FRZB during this differentiation results in inhibition
of hypertrophic differentiation and mineralization. The data
presented in the current manuscript shed light on the route taken
for mesenchymal stromal cells toward the chondrogenic pheno-
type and may be useful in determining strategies for selective
Figure 3. Analysis of changes in gene expression by micro-
array. Gene selection based on principal component analysis. A)
variance explained by components 1–6 from principal component
analysis. B) principal components 1, 2, and 3 as expression profiles. C)
selection of probes based on their factor 2 and 3 scores. D) scatterplot
view of gene data in respect to their correlation (factor score) to
principal components 2 and 3. Subgroups 1, 2, 3, and 4 are represented
by blue, green, yellow, and pink dots, respectively. Side-placed graphs
depict the gene expression profiles for genes found in the four
subgroups.
doi:10.1371/journal.pone.0044561.g003
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generation of either functional GP cartilage for research into
growth plate (GP) maturation and fusion or generation of
functional articular cartilage for tissue engineering strategies.
3.2 Differentiating hfMSCs show signs of early
chondrogenesis, not endochondral ossification and
matrix mineralization
In order to get insight into the requirement for a growth plate
gene expression profile, we generated a map of the protein-protein
interactions of the proteins of which the gene expression changed
more than 3.29 fold. We compared that map to a map of protein-
protein interactions of genes that change between undifferentiated
MSCs and growth plate chondrocytes. We observed the same
clusters of interacting proteins in both maps, and obtained clear
evidence that there is early hypertrophic differentiation, as
witnessed by the increased expression of collagen X. We obtained
less evidence for late hypertrophic differentiation, although
markers such as VEGF, LIF, PLAU, C1R and F13A1 are
upregulated during week 4+5 of chondrogenic differentiation. We
have found no indication of mineralization in our cultures. This
indicates that the chondrogenic differentiation of hfMSCs is a
good model for the early phases of growth plate development, but
under these conditions, not for the late phase. Other reports, more
specific in the field of bone tissue engineering have indicated
Figure 4. Gene expression of genes by KEGG signaling pathway. KEGG signaling pathways significantly associated with chondrogenic
differentiation of hfMSCs. For each pathway, genes showing the same distinct expression profile during 5 weeks of chondrogenic differentiation are
depicted as groups.
doi:10.1371/journal.pone.0044561.g004
Figure 5. Protein interactions of significantly changed genes after 5 weeks of chondrogenic differentiation. Analysis of protein
interactions of all genes that were$3.29-fold changed after 5 weeks of chondrogenic differentiation as compared to undifferentiated hfMSC (week 0)
using STRING9.0. Different clusters of interacting proteins can be identified, clusters A–F. Many other genes are identified that have no known protein
interactions with other genes in the list.
doi:10.1371/journal.pone.0044561.g005
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necessary specific supplements, such as T3, dexamethasone and
Wnt3a, for MSC differentiation into bone tissue, suggesting that
when these factors are added to our cultures during the later stages
of differentiation, one may observe induction of late hypertrophic
markers and mineralization [37–39].
The model we describe offers insight into the route that MSCs
take during the chondrogenic differentiated into growth plate
cartilage as depicted in figure 6. This enables us to perform
different types of research in the field of bone tissue engineering
and early growth plate differentiation To our knowledge this is the
first time human fetal mesenchymal stromal cells are followed on
their route toward the chondrogenic differentiation. We followed
the differentiation during 5 weeks with microarray data every week
and compared the obtained gene profiles to the gene expression
profile GP chondrocytes from prepubertal and fetal growth plate.
Using analysis of protein-protein interaction networks, we
observed that the typical markers for chondrogenesis and early
stages of hypertrophic differentiation are present, but other protein
clusters, such as genes important for late hypertrophy and
endochondral ossification are not induced. Using traditional
Figure 6. Protein interactions of differentially expressed genes between undifferentiated hfMSC and prepubertal growth plate
cartilage. Analysis of protein interactions of genes that are differentially expressed in undifferentiated hfMSC (week 0) compared to average
expression profiles of growth plate cartilage of 3 prepubertal donors using STRING 9.0. Large clusters of interacting proteins can be identified (A–F).
Many other genes are identified that have no known protein interactions with other genes in the list.
doi:10.1371/journal.pone.0044561.g006
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analysis methods, these observations were likely to be missed,
resulting in sub-optimal control of tissue formation. Moreover, the
data provide insight into the use of human fetal mesenchymal
stromal cells as an alternative to animal models for processes that
are not regulated in the same manner in various species. As a
model, it is readily accessible for genetic manipulation and might
be used for unraveling the molecular mechanisms underlying
growth regulation in the human epiphyseal plate during puberty.
As such it may find its use in the development of novel treatment
strategies for various growth disorders aimed at intervening in
growth plate maturation and fusion and bone tissue engineering.
Experimental Procedures
4.1 Cell culture
The use of human fetal material was approved by the medical
ethical committee of the Leiden University Medical Center and
written informed consent was obtained from the women under-
going elective abortion. Cell suspensions of fetal bone marrow
were obtained by flushing the long bones of fetuses with M199
washing medium. For the chondrogenic differentiation and
microarray analysis, cells derived from a single 22 week old fetus
were used. Red cells were depleted by incubation for 10 minutes
in NH4Cl (8.4 g/L)/KHCO3 (1 g/L) buffer at 4uC. Mononuclear
cells were plated at a density of 166104 cells/cm2 in M199 culture
medium (Gibco) supplemented with 10% fetal bovine serum (FBS),
1% penicillin/streptavidin (P/S), fungizone, endothelial cell
growth factor (ECGF) 20 mg/ml (Roche Diagnostics) and heparin
8 U/ml in culture flasks coated with 1% gelatin according to
previously established culture conditions for human fetal MSCs
[40]. Cultures were kept in a humidified atmosphere at 37uC with
5% CO2. The culture medium was changed twice per week. After
reaching near-confluence at passage 4 to 5 (15 population
doublings), hfMSCs were harvested by treatment with 0.5%
trypsin and 0.5% ethylenediaminetetraacetic acid (EDTA; Gibco)
for 5 minutes at 37uC and replated for chondrogenic differenti-
ation.
4.2 In vitro chondrogenic differentiation
hfMSCs (26105 cells/well) were cultured in cell pellets. Pellets
were formed by centrifugation of the cells at 1200 rpm for
4 minutes in U-shaped 96-well suspension culture plates (Greiner).
To induce chondrogenesis the pellets were cultured at 37uC with
5% CO2 in 200 ml of serum-free chondrogenic medium consisting
of high-glucose (25 mM) Dulbecco’s modified Eagle’s medium
(DMEM; Gibco) supplemented with 40 mg/ml proline (Sigma),
100 mg/ml sodium pyruvate (Sigma, USA), 50 mg/ml ITS
(insulin-transferrin-selenic acid) with Premix (BD Biosciences),
1% Glutamax (Gibco), 1% penicillin/streptavidin, 50 mg/ml
ascorbate-2-phosphate (Sigma), 1027 M dexamethasone (Sigma),
10 ng/ml transforming growth factor-b3 (TGFb3; R&D Systems),
500 ng/ml bone morphogenetic protein 6 (BMP6) and antibiotic
and antimycotic mix (0.06% polymixin, 0.2% kanamycin, 0.2%
penicillin, 0.2% streptavidin, 0.02% nystatin and 0.5% ampho-
tericin) as described by Sekiya et al., 2001 [41]. The medium was
changed twice per week for 5 weeks.
4.3 Histological analysis
Two pellets per time point (after 1, 2, 3, 4, or 5 weeks of
chondrogenesis) were used for histological evaluation. Pellets were
fixed in 10% formalin, dehydrated by treatment with graded
ethanols and processed for paraffin embedding. 5 mm sections
were cut using a Reichert Jung 2055 microtome (Leica). For each
pellet, only the midsagittal sections were mounted on glass slides.
Before histological (toluidine blue) or immunohistochemical
staining, sections were deparaffinized in xylene, treated with
graded ethanols followed by three washing steps with phosphate
buffered saline (PBS).
For immunofluorescence of collagen type II, sections were pre-
treated with 10 mM citric acid buffer (pH=6) for antigen
retrieval. Sections were incubated with a collagen type II
monoclonal antibody (clone 3HH1-F9, Abnova) at 1:100 dilution
in 1% bovine serum albumine (BSA)/PBS buffer overnight at 4uC.
After washing, sections were incubated with Alexa Fluor 488-Goat
anti-Mouse IgG1 (Invitrogen, Molecular Probes, diluted 1:1000 in
PBS/1% BSA) for 1 hour and protected from light. Sections were
counterstained with DAPI and mounted with vectashield.
For collagen type X immunohistochemistry, sections were
preincubated with blocking buffer (1% H2O2 in 40% methanol,
60% tris buffered saline) twice for 15 minutes at room tempera-
ture, followed by overnight incubation at 4uC with mouse
monoclonal antibody against collagen type X in a 1:100 dilution
(Quartett). Next, sections were incubated with the secondary
antibody biotinylated rabbit-anti-mouse IgG (DAKO) in a 1:300
dilution, followed by incubation with horseradish-peroxidase-
conjugated-streptavidine (Amersham Biosciences). Staining was
visualized with 3-amino-9-ethylcarbazole substrate in 0.2 mg/ml
acetate buffer (pH 5.2) with 0.04% H2O2. After counterstaining
with haematoxylin, the sections were mounted in Histomount
(National Diagnostics). Pictures of the stained pellets were taken
with a Nikon DXM 1200 digital camera using standardized
settings.
4.4 Patients and tissue preparation
Human proximal tibia growth plate tissues were collected from
patients at Tanner stage B1 undergoing surgery for different
medical conditions. The protocol used was approved by the
medical ethical committee of the Leiden University Medical
Center and written informed consent was obtained from the
patients as well as their parents. Epiphyseal samples were
embedded in Tissue-Tek (Sakura Finetek Europ BV, Zoeter-
woude, The Netherlands) and frozen in liquid nitrogen. RNA was
extracted according to the optimized method for RNA extraction
from cartilage as described by Heinrichs et al. [42].
4.5 RNA isolation from hfMSCs
Total RNA from 26106 undifferentiated hfMSCs derived from
the 22 weeks old fetus was extracted with Trizol (Invitrogen). After
1, 2, 3, 4, or 5 weeks of chondrogenesis, 60 pellets (per time point)
were pooled and homogenized in 1 ml 4 M guanidine isothiocy-
anate solution (Sigma) and RNA was extracted as described above.
The extracted total RNA was purified using the RNeasy kit
according to recommendations of the manufacturer (Qiagen).
4.6 Gene expression profiling
High RNA quality was confirmed by capillary electrophoresis
on an Agilent 2100 bioanalyzer (Agilent). Total RNA (100 ng) was
amplified and labeled using the GeneChip Two-Cycle cDNA
Synthesis Kit (Affymetrix) and the MEGAscript T7 Kit (Ambion).
For gene expression profiling, labeled cRNA was hybridized in
duplicate to Affymetrix Human Genome U133 PLUS 2.0 Array
Genechips. All procedures were carried out according to the
manufacturer’s recommendations.
Raw data from Affymetrix CEL files were analyzed using SAS
software package Microarray Solution version 1.3 (SAS Institute).
Custom CDF version 10 with Entrez based gene definitions [43]
was applied to map the probes to genes. Gene annotation was
obtained using the Affymetrix NetAffx website (http://www.
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affymetrix.com/analysis/index.affx). Quality control, normaliza-
tion and statistical modeling were performed by array group
correlation, mixed model normalization and mixed model analysis
respectively. The normalized expression values for each gene were
standardized by linearly scaling the values across all samples of the
time course to a mean of 0 with an SD of 1. Analysis of differential
gene expression was based on loglinear mixed model of perfect
matches [44]. A false discovery rate of a = 0.05 with Bonferroni-
correction for multiple testing was used to set the level of
significance. The raw and normalized data are deposited in the
Gene Expression Omnibus database (http://www.ncbi.nlm.nih.
gov/geo/; accession no. GSE40942) and followed MIAME
requirements.
4.7 Microarray data analysis
The statistical analysis of the microarray data was based on the
normalized mean expression values per probe at 6 time points with
2 replications at each time point (12 observations per probe). In
order to identify subgroups of probes with similar expression
profiles over time, a principal component analysis (PCA) of the co-
variance matrix was carried out on the mean expression value for
each probe at each time point. For each probe, factor scores for
principal components 1, 2 and 3 were obtained by regression
analysis of the 12 array results (6 time points in duplicate) for that
specific probe to those components. The first principal component
corresponded with the general expression level during the whole
experiment, whereas the second and third component corre-
sponded with changes over time. Since our interest was to identify
genes associated with the changes that occur during differentiation
from stromal cells towards chondrocytes, we focused our analysis
on the second and third component. By construction, these factor
scores had a mean of 0 with an SD of 1. Generally, the distribution
over the factor scores showed a normal distribution with outliers.
We used a cut-off of $3.29 to select outlying probes. This cut-off
would select 0.1% of the probes, if the factors scores would follow
a pure normal distribution that could be expected if the data were
pure noise. The presence of replications allowed us to assess the
statistical significance of the factor scores and to remove probes
that were not significant at the a=5% level.
4.8 Pathway and network analysis
Using sets of probes emerging from PCA, a search for relevant
KEGG pathways was performed using the DAVIDH Knowledge-
base, a publicly available bioinformatics tool for functional
annotation (http://david.abcc.ncifcrf.gov). To investigate known
and predicted associations between the protein products of the
genes that were more than 3.29-fold changed between week 0 and
week 5, we used STRING9.0 (string-db.org).
To visualize known and predicted associations between protein
products of the genes that were differentially expressed between
undifferentiated hfMSCs and pre-pubertal growth plate samples
we used STRING9.0. Growth plates of 3 donor with Tanner stage
B1 were included (one 12 year-old female with chondroid
osteosarcoma, one 8 year-old female with osteosarcoma, one 10
year-old male with cerebral palsy).
4.9 Quantitative real-time polymerase chain reaction
(qPCR)
RNA was transcribed into cDNA using the First Strand cDNA
Synthesis kit for qPCR (Roche Diagnostics) according to the
manufacturer’s protocol. Specific primer sets (available at www.
utwente.nl/tnw/DBE) were designed to amplify aggrecan (ACAN),
pannexin 3 (PANX3), epiphycan (EPYC), collagen type II
(COL2A1), and type X (COL10A1), SRY-box 9 (SOX9), WNT11,
lymphoid enhancer-binding factor 1 (LEF1), Gremlin 1 (GREM1).
b2-Microglobulin (B2M), and glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) were used as housekeeping genes. The
expression of these housekeeping genes was stable during
differentiation of hfMSCs as shown by the microarray analysis.
In order to test donor inter-variation, differentiated MSCs isolated
from other fetal donors were used for qPCR analysis as well.
All PCR reactions were performed in triplicate with 5 ng cDNA
and according to the manufacturer’s protocol of the iQTM SYBRH
Green Kit (Biorad) in a final volume of 20 ml. The cDNA was
amplified using the following thermal cycling conditions: one cycle
at 50uC for 2 min and 95uC for 10 min, followed by 40 cycles of
15 s at 95uC, 15 s at 60uC and 15 s at 72uC and finally a melting
curve was generated using the mIQ Single-Color—Real-Time
PCR System (BioRad Laboratories, Hercules, California, USA).
Fluorescence spectra were recorded and the threshold cycle
number (Ct) was calculated using the accompanying mIQ-
software. For each time point mean Ct was calculated and from
this value the fold difference in expression between undifferenti-
ated hfMSCs and differentiating cells using the 22DDCt method
was calculated using B2M as a reference as described by
Schmittgen and Livak, 2008 [45]. For visualization, this value
was log-transformed.
Supporting Information
Figure S1 There is a good correlation between qPCR
and microarray expression data. For (A) ACAN, (B) COL2A1,
(C) COL10A1, (D) SOX9, (E) PANX3, (F) EPYC, (G) WNT11, (H)
LEF1 and (I) GREM1 during 5 weeks of chondrogenic differen-
tiation of hfMSCs. qPCR data are expressed as delta delta CT
values corrected for the housekeeping gene B2M. The primary y-
axis (left) indicates the qPCR results as normalized mean fold
expression on a log-scale. The secondary y-axis (right) indicates the
microarray analysis results as least square means (lsm).
(TIF)
Table S1 List of genes selected with principal compo-
nent analysis.
(PDF)
Table S2 List of top hits of up regulated/down regulat-
ed genes at each time point with their fold change in
expression compared to undifferentiated hfMSCs.
(DOC)
Table S3 List of top hits of differentially expressed
genes of pre-pubertal GP with their fold change in
expression compared to undifferentiated hfMSCs.
(DOC)
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